OKYO Pharma Limited entered into an Underwriting Agreement with Piper Sandler & Co. to issue and sell 10,815,000 Ordinary Shares. The Company also granted the Underwriters an option to purchase up to 1,622,250 additional Ordinary Shares.
Key takeaways
OKYO Pharma Limited agreed to sell 10,815,000 Firm Shares to Underwriters led by Piper Sandler & Co.
The Underwriters received an option to purchase up to 1,622,250 additional Option Shares.
The offering is conducted under a Registration Statement on Form F-3 (File No. 333-293145).
The Registration Statement was declared effective by the SEC on 10 February 2026.
The Underwriting Agreement is dated February 12, 2026.